Tranexamic acid

Generic Name
Tranexamic acid
Brand Names
Cyklokapron, Lysteda
Drug Type
Small Molecule
Chemical Formula
C8H15NO2
CAS Number
1197-18-8
Unique Ingredient Identifier
6T84R30KC1
Background

Tranexamic acid is a synthetic derivative of lysine used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent.

It was first patented in 1957 and received its initial US approval in 1986.

Indication

Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema, cyclic heavy menstrual bleeding in premenopausal females, and other instances of significant bleeding in the context of hyperfibrinolysis. Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleed...

Associated Conditions
Bleeding, Heavy Menstrual Bleeding, Hereditary Angioedema (HAE)
Associated Therapies
-

Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

First Posted Date
2023-09-05
Last Posted Date
2023-11-01
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Target Recruit Count
150
Registration Number
NCT06023212
Locations
🇨🇳

the Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects

First Posted Date
2023-08-21
Last Posted Date
2024-04-03
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
48
Registration Number
NCT06000423
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Tranexamic Acid Dose and Confusion After Cardiac Surgery

Active, not recruiting
Conditions
First Posted Date
2023-07-28
Last Posted Date
2023-07-28
Lead Sponsor
Papworth Hospital NHS Foundation Trust
Target Recruit Count
5000
Registration Number
NCT05966012
Locations
🇬🇧

Royal Papworth Hospital NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom

Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty

First Posted Date
2023-07-21
Last Posted Date
2024-01-02
Lead Sponsor
Konkuk University Medical Center
Target Recruit Count
84
Registration Number
NCT05956769
Locations
🇰🇷

Soi Lee, Seoul, Korea, Republic of

🇰🇷

Konkuk University Medical Center, Seoul, Korea, Republic of

Tranexamic Acid in Percutaneous Nephrolithotomy

First Posted Date
2023-07-17
Last Posted Date
2023-07-19
Lead Sponsor
Haseki Training and Research Hospital
Target Recruit Count
75
Registration Number
NCT05947435
Locations
🇹🇷

Haseki Training and Research Hospital, Istanbul, Sultangazi, Turkey

Tranexamic Acid in Breast Esthetic Surgery.

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2023-07-14
Last Posted Date
2023-10-13
Lead Sponsor
Poznan University of Medical Sciences
Target Recruit Count
60
Registration Number
NCT05945680
Locations
🇵🇱

Poznan University of Medical Sciences, Poznań, Poland

Do Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood, Comparing to Patients Who Did Not?

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2023-06-27
Last Posted Date
2024-04-23
Lead Sponsor
Wolfson Medical Center
Target Recruit Count
80
Registration Number
NCT05921071
Locations
🇮🇱

Wolfson medical center, H̱olon, Israel

Perioperative Treatment With Tranexamic Acid in Melanoma

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2023-06-12
Last Posted Date
2024-01-19
Lead Sponsor
University of Aarhus
Target Recruit Count
1204
Registration Number
NCT05899465
Locations
🇩🇰

Aarhus University Hospital, Aarhus, Central Denmark Region, Denmark

🇩🇰

Aalborg University Hospital, Aalborg, North Denmark Region, Denmark

Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Treatment of Melasma

Phase 1
Completed
Conditions
Interventions
First Posted Date
2023-06-01
Last Posted Date
2023-06-01
Lead Sponsor
Combined Military Hospital Abbottabad
Target Recruit Count
60
Registration Number
NCT05884151
Locations
🇵🇰

Dr sana aslam, Abbottabad, Khyber Pakhtun Khwaa, Pakistan

🇵🇰

Sana aslam, Abbottābād, Khyber Pakhtun Khwa, Pakistan

Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements

First Posted Date
2023-05-11
Last Posted Date
2023-05-11
Lead Sponsor
Instituto Mexicano del Seguro Social
Target Recruit Count
20
Registration Number
NCT05855590
Locations
🇲🇽

Centro Médico Nacional de Occidente, Guadalajara, Jalisco, Mexico

© Copyright 2024. All Rights Reserved by MedPath